190 Timing of steroid doses and response rates to immune-checkpoint inhibitors in metastatic cancer

190 Timing of steroid doses and response rates to immune-checkpoint inhibitors in metastatic cancer

Bibliographic Details
Main Authors:	Richa Goel, Zoe Blake, Karine Tawagi, Diana Maslov, Victoria Simenson, Helen Yuan, Cameron Parent, Adi Bamnolker, KC Madhav, Marc Matrana
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Timing of steroid initiation and response rates to immune checkpoint inhibitors in metastatic cancer
by: Richa Goel, et al.
Published: (2021-07-01)

Cover_190
Published: (2020-05-01)

Progress of Steroids Effect on Efficacy of Immune Checkpoint Inhibitors
by: Guoqiang PAN, et al.
Published: (2019-12-01)

COVID-19 and Cold Agglutinin Hemolytic Anemia
by: Diana V. Maslov, et al.
Published: (2020-07-01)

Combination Strategies of Checkpoint Immunotherapy in Metastatic Breast Cancer
by: Liu ZB, et al.
Published: (2020-03-01)

The temperature of the hot DB GD 190
by: Provencal J. L., et al.
Published: (2000-03-01)

Biomarkers of the Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
by: Siteng Chen, et al.
Published: (2020-08-01)

Mucosal inflammation predicts response to systemic steroids in immune checkpoint inhibitor colitis
by: Melissa Lumish, et al.
Published: (2020-06-01)

Treatment of steroid‐resistant checkpoint inhibitor pneumonitis with pirfenidone: A case report
by: Kang Miao, et al.
Published: (2021-08-01)

P190 CARDIOVASCULAR DISEASE IN AXIAL SPONDYLOARTHRITIS
by: Tatyana Khan, et al.
Published: (2017-12-01)

BIM in bidding public works (190-196)
by: Ilidiane Correia de Oliveira, et al.
Published: (2018-12-01)

190. La obesidad en cirugía cardíaca
by: E. Berastegui García, et al.
Published: (2010-01-01)

Functional analysis of the centrosomal protein CP190
by: Chodagam, Sasidhar
Published: (2003)

Portugués intermedio 1 - TR190 201801
by: Universidad Peruana de Ciencias Aplicadas (UPC), et al.
Published: (2018)

Crystal structure of cerium silver phosphide (1:1.08:1.90), CeAg1.08P1.90
by: Demchyna R., et al.
Published: (2002-12-01)

Crystal structure of cerium silver phosphide (1:1.08:1.90), CeAg1.08P1.90
by: Demchyna R., et al.
Published: (2002-12-01)

Crystal structure of cerium silver phosphide (1:1.08:1.90), CeAg1.08P1.90
by: Demchyna R., et al.
Published: (2002-06-01)

Primary colon adenocarcinoma with choriocarcinoma differentiation: a case report and review of the literature
by: Jessica Boyce, et al.
Published: (2020-11-01)

Calcineurin inhibitors in steroid and anti‐TNF‐alpha refractory immune checkpoint inhibitor colitis
by: Eva Zhang, et al.
Published: (2021-05-01)

Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipients
by: Richard Carvajal, et al.
Published: (2020-06-01)

Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma
by: Nicholas D. Klemen, et al.
Published: (2020-06-01)

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?
by: Passiglia F, et al.
Published: (2021-02-01)

Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
by: Teresa Kim, et al.
Published: (2014-12-01)

Metastatic sarcomatoid renal cell carcinoma treated with immune checkpoint inhibitors
by: Ahmad Hanif, et al.
Published: (2019-08-01)

Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma
by: Pouyan N. Changizzadeh, et al.
Published: (2017-12-01)

Concomitant Radioembolization and Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma
by: Jacob J. Adashek, et al.
Published: (2018-05-01)

Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma
by: Kalijn Fredrike Bol, et al.
Published: (2019-10-01)

LDH Isotyping for Checkpoint Inhibitor Response Prediction in Patients with Metastatic Melanoma
by: Sandra van Wilpe, et al.
Published: (2021-04-01)

Immune checkpoint inhibitor‐related gastritis in a patient with metastatic melanoma
by: Yuya Sugiyama, et al.
Published: (2021-10-01)

Redes De Comunicaciones 1-EL190-201801
by: Campos Aguado Fredy, et al.
Published: (2020)

Redes De Comunicaciones 1-EL190-201802
by: Campos Aguado Fredy, et al.
Published: (2020)

Redes De Comunicaciones 1-EL190-201901
by: Gonzales Figueroa Renatto Gustavo, et al.
Published: (2020)

miR-190-5p in human diseases
by: Yue Yu, et al.
Published: (2019-10-01)

Dipole transitions in superdeformed nuclei in the A=190 region
by: Wilson, Anna Naomi
Published: (1996)

High K-isomers in the A = 170-190 region
by: Wood, Rachael
Published: (2018)

Anti-metastatic Action of Non-steroidal Anti-inflammatory Drugs
by: Wen-Chun Hung
Published: (2008-08-01)

Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
by: Nicoletta Zilembo, et al.
Published: (2019-02-01)

Sequential Treatment With Targeted and Immune Checkpoint Therapy in Patients With BRAF Positive Metastatic Melanoma: The Importance of Timing?
by: Victoria Grätz, et al.
Published: (2019-12-01)

Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis
by: Margaret Gatti-Mays
Published: (2021-02-01)

DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
by: Bastian Schilling, et al.
Published: (2021-07-01)